Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

The First Genetic Test for Hair Loss: Introducing TrichoTest, from Fagron

PR Newswire June 2, 2021

Kintara Therapeutics to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

PR Newswire June 2, 2021

Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders

PR Newswire June 2, 2021

PharmAbcine to Present at the BIO Digital International Convention 2021

PR Newswire June 2, 2021

NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021

PR Newswire June 2, 2021

Health Monitor Network Expands Senior Leadership Team in Response to Continued Growth

PR Newswire June 2, 2021

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

PR Newswire June 2, 2021

LogicBio Therapeutics Announces First Patient Dosed in Groundbreaking Phase 1/2 SUNRISE Clinical Trial for the Treatment of Pediatric Patients Suffering from Methylmalonic Acidemia

PR Newswire June 2, 2021

Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer

PR Newswire June 2, 2021

Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE(TM) (triamcinolone acetonide suprachoroidal injectable suspension)

Canada NewsWire June 2, 2021

Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Update Regarding Clinical Development of PRX-102 for Treatment of Fabry Disease

PR Newswire June 2, 2021

Obatala Sciences licenses technology from Harvard University to advance discovery in obesity, diabetes, and cancer

PR Newswire June 2, 2021

ImmVira will present the U.S. Clinical Phase I Study Results of MVR-T3011 via Intratumoral Administration at ASCO 2021

PR Newswire June 2, 2021

Orexo continues to strengthen ZUBSOLV´s patent portfolio with two new patents

PR Newswire June 2, 2021

Antengene Announces Abstracts on Twelve Clinical Studies of Selinexor Selected by EHA 2021

PR Newswire June 1, 2021

Transcenta Announced Completion of First Patient Dosing in PET-CT Imaging Study of Radionuclide-Labeled CLDN18.2 Antibody

PR Newswire June 1, 2021

Antengene Announces Fifteen Clinical Studies and Results of Selinexor to be Presented at ASCO 2021

PR Newswire June 1, 2021

OLUMIANT® Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses

PR Newswire June 1, 2021

Amgen to Webcast Investor Meeting at ASCO 2021

PR Newswire June 1, 2021

Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis

PR Newswire June 1, 2021